Polymorphic CYP genes and disease predisposition - What have the studies shown so far?

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 167-171

  Watanabe, Minro ^a  

^a IWATE PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Cancer susceptibility; Drug metabolizing enzymes; Genetic polymorphism; Lung cancer; Urinary bladder cancer

Indexed keywords

ACYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; ANDROGEN RECEPTOR; AROMATASE; AROMATIC HYDROCARBON RECEPTOR; ARYLESTERASE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DIHYDROPYRIMIDINE DEHYDROGENASE; DIMETHYLNITROSAMINE DEMETHYLASE; DRUG METABOLIZING ENZYME; EPOXIDE HYDROLASE; ESTROGEN RECEPTOR; ETHOXYRESORUFIN DEETHYLASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; RECEPTOR PROTEIN; THIOPURINE METHYLTRANSFERASE; VITAMIN D RECEPTOR;

BLADDER CANCER; CANCER; CANCER RISK; CIGARETTE SMOKING; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; PRIORITY JOURNAL;

CYTOCHROME P-450 ENZYME SYSTEM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; SMOKING;

EID: 0032435449     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00303-8     Document Type: Conference Paper

References (17)

1. Ambrosone, C.B., Freudenheim, J.L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, J.R., Laughlin, R., Nemoto, T., Michalek, A.M., Harrington, A., Ford, T.D., Shields, P.G., 1995. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 55, 3483-3485.
2. Caporaso, N.E., 1995. The genetics of lung cancer. In: Ponder, B.A.J., Waring, M.J. (Eds.), The Genetics of Cancer. Kluwer Academic, Dordrecht, pp. 21-43.
3. Claus, E.B., 1995. The genetic epidemiology of cancer. In: Ponder, B.A.J., Cavenee, W.K., Solomon, E. (Eds.), Cancer Surveys, vol. 25, Genetics and Cancer: A Second Look. Cold Spring Harbor Laboratory Press, New York, pp. 13-26.
4. Gonzalez, F.J., 1993. Cytochrome P450 in humans. In: Schenkman, J.B., Greim, H. (Eds.), Handbook of Experimental Pharmacology, vol. 105. Springer-Verlag, Berlin, pp. 239-257.
5. Ishibe, N., Wiencke, J.K., Zuo, Z.-F., McMillan, A., Spitz, M., Kelsey, K.T., 1997. Susceptibility to lung cancer in light smokers, associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol. Biomarkers Prev. 6, 1075-1080.
6. Jourenkova, N., Reinikanen, M., Bouchardy, C., Husgafvel-Pursiainen, K., Dayer, P., Benhamou, S., Hirvonen, A., 1997. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics 7, 515-518.
7. Kato, S., Bowman, E.D., Harrington, A.M., Blomeke, B., Shields, P.G., 1995. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87, 902-907.
8. Kihara, M., Kihara, M., Noda, K., 1995. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combination of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16, 2331-2336.
9. London, S.J., Daly, A.K., Cooper, J., Navidi, W.C., Carpenter, C.L., Idle, J.R., 1995. Polymorphism of glutathione 5-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst. 87, 1246-1252.
10. Nakachi, K., Iwai, K., Hayashi, S., Watanabe, J., Kawajiri, K., 1991. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51, 5177-5180.
11. Nakachi, K., Hayashi, S.-I., Kawajiri, K., Iwai, K., 1995. Association of cigarette smoking and CYP1A1 polymorphism with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis 16, 2209-2213.
12. Nebert, D.W., 1997. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am. J. Hum. Genet. 60, 265-271.
13. Park, J.Y., Muscat, J.E., Ren, Q., Schantz, S.P., Harwick, R.D., Ste, J.C., Pike, V., Richie, J.P., Jr., Lazarus, P., 1997. CYP1A1 and GSTM1 polymorphism and oral cancer risk. Cancer Epidemiol. Biomarkers Prev. 6, 791-797.
14. Raunio, H., Husgafvel-Pursianen, K., Anttila, S., Hietanen, E., Hirvonen, A., Pelkonen, D., 1995. Diagnosis of polymorphisms in carcinogen activating and inactivating enzymes and cancer susceptibility - a review. Gene 159, 113-121.
15. Shields, P.G., 1996. Molecular epidemiology. In: Walker, C., Groopman, J., Slaga, T.J., Klein-Szanto, A. (Eds.), Genetics and Cancer Susceptibility: Implications for Risk Assessment. Wiley-Liss, New York, pp. 141-157.
16. Smith, G., Stanley, L.A., Sim, E., Strange, R.C., Wolf, C.R., 1995. Metabolic polymorphisms and cancer susceptibility. In: Ponder, B.A.J., Cavenee, W.K., Solomon, E. (Eds.), Cancer Surveys, vol. 25, Genetics and Cancer: A Second Look. Cold Spring Harbor Laboratory Press, New York, pp. 27-65.
17. Uematsu, F., Ikawa, S., Kikuchi, H., Kanamaru, R., Abe, T., Satoh, K., Motomiya, M., Watanabe, M., 1994. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450 IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 4, 58-63.